Table 2.
Key clinical publications on schistosomiasis and malaria coinfection.
Organisms | Country | Findings | Ref. |
---|---|---|---|
Schistosoma haematobium | Malawi | S. haematobium associated with lower malaria parasite densities | [74] |
S. haematobium | Gabon | S. hematobium was not found to be associated with malaria infection | [59] |
S. haematobium | Kenya | Schistosomiasis was not associated with malaria susceptiblity | [76] |
Schistosoma mansoni | Uganda | No association between S. mansoni and malaria infection found | [71] |
S. mansoni, S. haematobium | Zimbabwe | S. mansoni infection associated with Plasmodium falciparum malaria infection | [70] |
S. haematobium | Mali | Levels of Tregs were lower in malaria–S. haematobium coinfected children versus children with malaria alone. Increased Tregs were associated with decreased serum Th1 cytokine levels and elevated parasitemia | [86] |
S. haematobium | Mali | IL-6 and IL-10 elevations in acute malaria were blunted in schistosomiasis-infected children from 4 to 8 years old | [85] |
S. haematobium | Senegal | Subjects with low-density S. haematobium had lower P. falciparum parasitemia | [83] |
S. haematobium | Mali | Prospective study demonstrating delay in time to clinical malaria infection, decreased number of malaria episodes and decreased Plasmodium parasitemia among schistosomiasis-infected children | [86] |
S. mansoni | Senegal | S. mansoni-infected individuals had increased incidence of clinical malaria. Effect most apparent in those with high schistosomiasis organism burden. Nonsignificant observation that malaria attack rates were lower in ‘medium-grade’ S. mansoni infections | [80] |